Table 4

Predisposing factors for bloodstream infection in febrile episodes of neutropenic and non- neutropenic patients in radiotherapy, chemotherapy and radio chemotherapy treated cases
Causative factors Group = 1 Group = II Group = III
ANC ANC ANC
<500 ≥500 <500 ≥500 <500 ≥500
Duration of neutropenia >7 5(7.81) 4(4.70) 6(6.6) 4(7.27) 10(8.92) 6(6.31)
P = 0.49 P = 1 P = 0.65
Oral mucositis (grade 0) 5(7.81) 3(3.52) 5(5.55) 4(7.27) 5(4.46) 2(1.78)
P = 0.28 P = .73 P = .45
Oral mucositis (grade 1) 6(9.37) 3(3.52) 2(2.22) 5(9.09) 7(6.25) 6(6.31)
P = 0.17 P = 0.10 P = .78
Oral mucositis (grade 2) 4(6.25) 5(5.88) 4(4.44) 5(9.09) 12(10.71) 4 (4.21)
P = 1 P = 0.30 P = .13
Oral mucositis (grade 3) 5(7.81) 8(9.41) 9(10) 6(10.90) 15(13.39) 7(7.36)
P = 0.78 P = 0.91 P = .23
Oral mucositis (grade 4) 7(10.93) 25(29.41) 11(12.22) 12(21.81) 32(28.57) 12(12.63)
P < .01** P =0.19 P < .001***
Anemia 4(6.25) 3(3.52) 10(11.11) 3(5.45) 9(8.03) 6(6.31)
P = .46 P = .37 P = .83
Central venous line present 8(12.5) 7(8.23) 15(16.6) 5(9.09) 7(6.25) 15(15.78)
P = .56 P = .30 P = .05*
Peripheral line present 5(7.81) 3(3.52) 9(10) 5(9.09) 4(3.57) 10(10.52)
P = .02 P = 91 P = .08
Community acquired 6(9.37) 20(23.52) 6(6.06) 2(3.63) 6(5.35) 11(11.57)
P < .05* P = .71 P = .17
Nosocomial acquired 9(14.06) 4(4.70) 13(14.44) 4(7.27) 5(4.46) 16(16.84)
P = .08 P = .29 P < .001***

Note: % had been shown in parenthesis, the value in table shows number of patients, ANC = absolute neutrophil count, ANC of <500 neutrophil/micro L (neutropenic), ANC ≥500 neutrophil/micro L (non-neutropenic). P = Probability value with an ANC of <500 neutrophil/micro L (neutropenic) vs. those with ANC >500 neutrophil/micro L (non-neutropenic). P < .05 * less significant, P < .01 ** significant, P < .001 *** highly Significant.

Panghal et al.

Panghal et al. BMC Oral Health 2012 12:22   doi:10.1186/1472-6831-12-22

Open Data